FORLEO, Cinzia
 Distribuzione geografica
Continente #
NA - Nord America 3.735
EU - Europa 891
AS - Asia 371
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.002
Nazione #
US - Stati Uniti d'America 3.732
CN - Cina 316
SE - Svezia 280
IT - Italia 245
UA - Ucraina 80
DE - Germania 75
FI - Finlandia 64
GB - Regno Unito 44
FR - Francia 40
SG - Singapore 33
BE - Belgio 17
CZ - Repubblica Ceca 11
IE - Irlanda 11
IN - India 9
NL - Olanda 7
CH - Svizzera 6
VN - Vietnam 6
RU - Federazione Russa 4
BR - Brasile 3
CA - Canada 3
HK - Hong Kong 3
IR - Iran 3
ES - Italia 2
SI - Slovenia 2
BG - Bulgaria 1
CL - Cile 1
EU - Europa 1
KR - Corea 1
LV - Lettonia 1
RO - Romania 1
Totale 5.002
Città #
Fairfield 502
Chandler 398
Woodbridge 392
Houston 325
Ashburn 281
Nyköping 230
Ann Arbor 191
Cambridge 189
Jacksonville 185
Wilmington 165
Seattle 163
Bari 106
Roxbury 80
Lawrence 79
Nanjing 76
Beijing 65
New York 65
Des Moines 48
Inglewood 39
Boardman 34
San Diego 32
Princeton 26
Singapore 23
Hebei 20
Shenyang 19
Brussels 17
Brooklyn 16
Dearborn 15
Nanchang 14
Jinan 12
Marseille 12
Paris 12
San Mateo 12
Brno 11
Dublin 11
Milan 11
Munich 11
Tianjin 11
Helsinki 9
Jiaxing 9
Leawood 9
London 9
Shanghai 9
Falls Church 8
Naples 8
Changsha 7
Guangzhou 7
Augusta 6
Dong Ket 6
Foggia 6
Ravenna 6
Redwood City 6
Monmouth Junction 5
Stimigliano 5
Wuhan 5
Norwalk 4
Valenzano 4
Zhengzhou 4
Amsterdam 3
Ardabil 3
Auburn Hills 3
Fuzhou 3
Grottaglie 3
Hefei 3
Kunming 3
Los Angeles 3
Molfetta 3
Pune 3
Romanel-sur-Lausanne 3
San Francisco 3
Triggiano 3
Washington 3
Wuxi 3
Yiwu 3
A Coruña 2
Angeren 2
Atrani 2
Bengaluru 2
Chiswick 2
Forlimpopoli 2
Grumo Appula 2
Hangzhou 2
Hong Kong 2
Ljubljana 2
Miami 2
New Bedfont 2
Nürnberg 2
Osio Sotto 2
Padova 2
Pavia 2
Pescara 2
Pradinas 2
Rho 2
Riccione 2
Selargius 2
Sesto Fiorentino 2
Shenzhen 2
Syracuse 2
Tiantai Chengguanzhen 2
Toronto 2
Totale 4.130
Nome #
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 138
Targeted next-generation sequencing detects novel gene- phenotype associations and expands the mutational spectrum in cardiomyopathies 121
Functional study of a KCNH2 mutant: Novel insights on the pathogenesis of the LQT2 syndrome 119
Time-dependent benefits of pre-treatment with new oral P2Y12 -inhibitors in patients addressed to primary PCI for acute ST-elevation myocardial infarction 118
Independent Role of Left Ventricular Global Longitudinal Strain in Predicting Prognosis of Chronic Heart Failure Patients. 117
Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis 105
Clinical and functional characterization of a novel mutation in lamin a/C gene in a multigenerational family with arrhythmogenic cardiac laminopathy 104
Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy 103
Beta1-Adrenergic Receptor Polymorphisms Predict Heart Failure Progression in Idiopathic Dilated Cardiomyopathy 95
Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype 91
null 88
Left ventricular ejection fraction and b2-adrenergic receptor polymorphism in dilated cardiomyopathy 85
Clinical predictors of head-up tilt test outcome during the nitroglycerin phase 84
The 212A Variant of the APJ Receptor Gene for the Endogenous Inotrope Apelin is Associated With Slower Heart Failure Progression in Idiopathic Dilated Cardiomyopathy 82
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 82
Prognostic value of brain natriuretic peptide in the management of patients receiving cardiac resynchronization therapy 82
SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene 80
Ventricular Asynchrony Predicts a Better Outcome in Patients With Chronic Heart Failure Receiving Cardiac Resynchronization Therapy 79
Endothelin system polymorphisms in tilt test-induced vasovagal syncope 79
Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy 77
null 77
Independent role of high central venous pressure in predicting worsening of renal function in chronic heart failure outpatients 76
Alpha- and beta-adrenergic receptor polymorphisms in hypertensive and normotensive offspring 75
Role of nuclear Lamin A/C in cardiomyocyte functions 75
Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy 74
Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis. 72
Prognostic significance of bioelectrical evaluation of body composition in chronic heart failure 72
Role of septal to posterior wall motion delay in cardiac resynchronization therapy 70
null 70
Head-up tilt testing for diagnosing vasovagal syncope: A meta-analysis 69
Nitrate-Potentiated Head-Up Tilt Testing in Older Patients: Outcomes, Hemodynamic Responses and Prodrome Recognition 67
Reversibility of the endothelial dysfunction after CPAP therapy in OSAS patients 67
Blood pressure control and treatment adherence in hypertensive patients with metabolic syndrome: protocol of a randomized controlled study based on home blood pressure telemonitoring vs. conventional management and assessment of psychological determinants of adherence (TELEBPMET Study). 66
Altered two-dimensional strain measures of the right ventricle in patients with Brugada syndrome and arrhythmogenic right ventricular dysplasia/cardiomyopathy 66
Functional characterization of a newly identified LMNA mutant in HL-1 cardiomyocytes 65
Prevalence, timing, and haemodynamic correlates of prodromes in patients with vasovagal syncope induced by head-up tilt test 63
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 63
Alpha1a-Adrenergic Receptor Polymorphisms Influences Baroreflex Sensitivity and Nonsustained Ventricular Tachycardia in Idiopathic Dilated Cardiomyopathy 62
Echocardiographic characteristics of unaffected relatives of patients with familial and non-familial idiopathic dilated cardiomyopathy 60
Independent role of reduced arterial baroreflex sensitivity during head-up tilt testing in predicting vasovagal syncope recurrence 58
Arg16Arg genotype of the beta2-adrenergic receptor predicts lower risk for major arrhythmic events in patients with idiopathic dilated cardiomyopathy 58
Methodical approach to collecting and preserving plasma samples containing B-type natriuretic peptide 57
Lack of association between genetic polymorphisms affecting sympathetic activity and tilt-induced vasovagal syncope 57
Beyond BRCA1/2: Homologous Recombination Repair Genetic Profile in a Large Cohort of Apulian Ovarian Cancers 57
Shortened head-up tilting test guided by systolic pressure reductions in neurocardiogenic syncope 56
High circulating levels of endogenous ouabain in the offspring of hypertensive and normotensive individuals 50
Impaired arterial baroreflex function before nitrate-induced vasovagal syncope during head-up tilt test 50
Left ventricular hypertrophy and ventricular pre-excitation: let’s not forget Danon disease 49
I livelli plasmatici dell’angiotensina II predicono la risposta alla terapia nei pazienti con scompenso cardiaco 47
null 46
Cardiogenic Shock following Acute Myocardial Infarction: What's New? 46
Association of β-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy 45
VINYL: Variant prIoritizatioN by survivaL analysis 44
Independent prognostic role of arterial baroreflex control of heart rate in predicting heart failure progression in idiopathic dilated cardiomyopathy 43
Screening For Sarcomere Protein Gene Mutations and Genotype-Phenotype Correlations in Patients with Hypertrophic Cardiomyopathy: experience of a Single Centre 43
Left ventricular hypertrophy: when to suspect Anderson-Fabry disease? 43
Beta1- and Beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy 42
Independent prognostic value of baroreflex sensitivity in idiopathic dilated cardiomyopathy 42
Role of Beta1-Adrenergic receptor polymorphysms in predicting heart failure progression in idiopathic dilated cardiomyopathy 41
null 41
Sarcomere gene mutations and clinical correlates in patients with hypertrophic cardiomyopathy 39
Genetic and phenotypic heterogeneity in hypertrophic cardiomyopathy: our experience by using targeted next-generation sequencing 39
Role of polymorphysms in the Beta1-Adrenergic receptor in susceptibility to idiopathic dilated cardiomyopathy 38
Left ventricular systolic dysfunction and conduction system disorders: when do you think about cardiolaminopathy? 37
Pro-inflammatory cytokines as emerging molecular determinants in cardiolaminopathies 37
QT interval prolongation in right precordial leads: an additional electrocardiographic hallmark of Brugada Sindrome 34
Effetti cardiotossici in pazienti sottoposti a terapia antineoplastica 34
Two-dimensional strain measures of left ventricular systolic function are independent predictors of mortality in patients affected by chronic heart failure. 34
Importance of clinical suspicion and multidisciplinary management for early diagnosis of a cardiac laminopathy patient: A case report 34
Role of beta1-adrenergic receptor polymorphisms in susceptibility to idiopathic dilated cardiomyopathy 33
QT-interval prolongation in right precordial leads: an additional electrocardiographic hallmark of Brugada syndrome 31
Cardiovascular prevention in women: A narrative review from the Italian Society of Cardiology working groups on 'Cardiovascular Prevention, Hypertension and peripheral circulation' and on 'Women Disease' 30
Genotypes and phenotypes heterogeneity in PIK3CA-related overgrowth spectrum and overlapping conditions: 150 novel patients and systematic review of 1007 patients with PIK3CA pathogenetic variants 30
Genetic evaluation of Brugada sindrome 29
null 28
Natriuretic peptides and essential arterial hypertension 25
SCN5A polymorphism rescues Brugada Syndrome Mutation 24
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study 24
Role of beta2-adrenergic receptor polymorphisms in predicting lower risk for major arrhythmic events in idiopathic dilated cardiomyopathy 23
Independent and incremental prognostic role of two-dimensional speckle tracking analysis of left ventricular systolic function in predicting heart failure outpatients’ prognosis 21
A novel LMNA gene mutation in a multigenerational family with arrhythmogenic cardiac laminopathy 19
The expression of Lamin A mutant R321X leads to endoplasmic reticulum stress with aberrant Ca(2+) handling 18
Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary haemorrhagic telangiectasia and atrial fibrillation. 18
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 17
Incidence and prevalence of hypothyroidism in patients affected by chronic heart failure: role of amiodarone 16
Autoimmune diseases in patients undergoing percutaneous coronary intervention: A risk factor for in-stent restenosis? 15
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 15
Inflammatory bowel disease and acute coronary syndromes: From pathogenesis to the fine line between bleeding and ischemic risk. 14
Time-dependent benefits of pre-treatment with new oral P2Y12 -inhibitors in patients addressed to primary PCI for acute ST-elevation myocardial infarction 14
A Young Patient Presenting with Dilated Cardiomyopathy and Renal Infarction during Treatment with Isotretinoin: Mere Coincidence or Serious Side Effect of a Drug Commonly Used in Adolescence? 14
Targeting unfolded protein response reverts ER stress and ER Ca2+ homeostasis in cardiomyocytes expressing the pathogenic variant of Lamin A/C R321X 14
Predictors of exercise capacity in dilated cardiomyopathy with focus on pulmonary venous flow recorded with transesophageal eco-doppler 14
Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients 13
Cardiac Magnetic Resonance as Risk Stratification Tool in Non-Ischemic Dilated Cardiomyopathy Referred for Implantable Cardioverter Defibrillator Therapy—State of Art and Perspectives 11
Improvement of Left Ventricular Global Longitudinal Strain after 6-Month Therapy with GLP-1RAs Semaglutide and Dulaglutide in Type 2 Diabetes Mellitus: A Pilot Study 10
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 9
Role of pre-operative embolization in carotid body tumor surgery according to Shamblin classification: A systematic review and meta-analysis 9
Role of Nuclear Lamin A/C in the Regulation of Nav1.5 Channel and Microtubules: Lesson From the Pathogenic Lamin A/C Variant Q517X 9
Improvement of myocardial contractility with leadless endocardial single-lead atrial sensing ventricular pacing in patients with prolonged PQ interval 8
Bifocal coronary sinus pacing and transcatheter tricuspid valve-in-valve implantation: an innovative combined approach 8
Totale 5.142
Categoria #
all - tutte 22.228
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.228


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.032 0 63 43 135 134 82 128 109 143 71 94 30
2020/2021695 51 41 49 35 46 36 74 52 59 107 90 55
2021/2022636 40 84 16 21 22 44 31 31 45 52 105 145
2022/20231.079 128 116 76 94 129 142 13 114 197 11 32 27
2023/2024421 31 68 18 36 34 91 18 26 11 16 13 59
2024/2025130 118 12 0 0 0 0 0 0 0 0 0 0
Totale 5.208